Peptides vs SARMs: What Is the Difference?

The Core Difference Between Peptides and SARMs

The simplest distinction is a chemical one. Peptides are short chains of amino acids, the same class of building block that makes up proteins, while SARMs (selective androgen receptor modulators) are synthetic small-molecule compounds that are not built from amino acids at all. In other words, the two terms describe entirely different molecular classes, not two versions of the same thing.

Because they belong to different chemical families, peptides and SARMs are studied, characterised and regulated in different ways. The sections below compare the two classes in neutral biochemical and regulatory terms. None of this is guidance for human or animal use. The compounds discussed here are laboratory research materials only.

What Peptides Are

A peptide is a short sequence of amino acids joined by peptide bonds. Where a long chain folds into a functional protein, a peptide is typically much shorter, often ranging from a couple of amino acids up to a few dozen. Many signalling molecules found in biology, including a range of hormones and growth factors, are peptides or peptide-like structures.

In research contexts, peptides are studied as a broad and diverse group. Two different peptides can have completely different sequences, shapes and biochemical behaviour, so the word peptide describes a structural category rather than a single type of activity. This diversity is one reason peptides are discussed separately from other compound classes.

• Molecular class: short amino-acid chains
• Building blocks: amino acids joined by peptide bonds
• Diversity: sequence and length vary widely between individual peptides
• General size: larger and more complex than typical small-molecule drugs

What SARMs Are

SARMs, or selective androgen receptor modulators, are synthetic small-molecule compounds. Unlike peptides, they are not made of amino acids. The defining feature in their name is selectivity: they are described in the research literature as compounds designed to interact with the androgen receptor in a tissue-selective manner, acting as an agonist in some tissues and showing minimal or no activity in others.

Commonly referenced research-named SARMs include ostarine (enobosarm), ligandrol (LGD-4033), andarine, RAD140 and S-23, among others. As with peptides, naming a compound here is for identification and comparison only and does not imply any approved or intended use.

• Molecular class: synthetic small-molecule ligands
• Not amino-acid chains
• Named target: the androgen receptor
• Defining concept: tissue-selective receptor modulation

Mechanism: How the Two Classes Differ

The mechanisms described for the two classes sit at opposite ends of a spectrum. SARMs are characterised by a single, well-defined target. The scientific literature describes them as binding selectively to the androgen receptor, which is why the word selective appears in their name.

Peptides, by contrast, do not share one common target. Because a peptide is defined by its structure rather than by what it binds, different peptides are studied in connection with many different receptors and signalling pathways. There is no single peptide mechanism, which is a key reason the two classes cannot be compared on a like-for-like basis.

• SARMs: one named receptor target (the androgen receptor), selective modulation
• Peptides: no single shared target, many different receptors and pathways across the class
• Comparison limit: peptide is a structural category, SARM is a mechanistic category

Molecular Size, Stability and Half-Life as a Class Contrast

At a general biochemistry level, the two classes also differ in physical characteristics, though specifics vary from compound to compound and should not be generalised into claims about any single substance. As a broad rule, peptides are larger, more complex molecules built from amino acids, which can make them more sensitive to breakdown by enzymes and to handling conditions such as temperature.

Small-molecule compounds like SARMs are generally smaller and structurally simpler than peptides. These are class-level observations only. Individual half-life, stability and storage behaviour depend heavily on the exact compound and its formulation, and any figures would need to be verified against primary data for that specific substance.

• Peptides: generally larger, amino-acid-based, can be sensitive to enzymatic breakdown and handling
• SARMs: generally smaller, structurally simpler small molecules
• Caveat: half-life and stability are compound-specific, not class-wide constants

Regulatory Status in Australia

In Australia, medicines and chemicals are classified under the Poisons Standard, formally the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP), administered by the Therapeutic Goods Administration (TGA). SARMs as a group were scheduled by the TGA, with SARMs captured under Schedule 4 (Prescription Only Medicine). Publicly available TGA scheduling information is the authoritative source for the current status of any specific compound, and status can change between editions of the Poisons Standard.

Many research peptides are not approved for supply as medicines in Australia and do not appear on the Australian Register of Therapeutic Goods (ARTG), which lists therapeutic goods that may be legally supplied. Where a compound is not ARTG-registered, it has not been evaluated by the TGA as a medicine. Compounds supplied for laboratory research are provided on a research-use-only basis and are not for human or animal use. Scheduling and approval status differ from compound to compound, so each substance should be checked individually against current TGA records.

• Framework: the Poisons Standard (SUSMP), administered by the TGA
• SARMs: scheduled by the TGA, with SARMs captured under Schedule 4 (Prescription Only Medicine)
• Many research peptides: not ARTG-registered and not approved as medicines
• Always verify: scheduling and ARTG status are compound-specific and can change

Research peptides in Australia: a buyer's guide

WADA Status in Sport

Both classes also appear on the World Anti-Doping Agency (WADA) Prohibited List, but in different categories. SARMs are listed under S1 Anabolic Agents. Peptide hormones, growth factors and related substances fall under S2 of the same list. The WADA Prohibited List is updated periodically, so athletes and anti-doping bodies refer to the current edition for the authoritative position.

This is included only to illustrate that the two classes are treated as distinct categories by a major regulatory body, consistent with their different chemistry and mechanisms. It is not advice about participation in sport.

• SARMs: WADA category S1 (Anabolic Agents)
• Peptide hormones and growth factors: WADA category S2
• Reference: the current WADA Prohibited List is the authoritative source

Why the Comparison Matters for Research Context

Because peptides and SARMs are frequently discussed together online, it is easy to assume they are interchangeable. They are not. One is a structural category of amino-acid chains with many different mechanisms, and the other is a mechanistically defined group of synthetic small molecules targeting a single receptor. Their chemistry, their stability profiles and their regulatory treatment all differ.

For anyone reading about these compounds, the most useful takeaway is to treat each individual substance on its own terms: confirm its exact identity, its documented chemistry and its current regulatory status from primary sources rather than relying on class-level shorthand. Related educational material on purity and testing may help build that background understanding.

What purity means for research peptides Third-party tested peptides explained